HAIXI PHARMA(02637): Lam Wai Yee appointed as Joint Company Secretary.
Haisi Pharmaceuticals (02637) announced that Ms. Chen Xiaolin has resigned as (i) Joint Company Secretary of the company; (ii) ...
HAIXI PHARMA (02637) announces that Ms. Chen Xiaolin has resigned as (i) Joint Company Secretary of the Company; (ii) Company authorized representative as defined under Rule 3.05 of the Listing Rules of the Stock Exchange of Hong Kong Limited; (iii) Company authorized representative under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong); and (iv) Company authorized person to accept legal process documents and notices in Hong Kong as specified under Rule 19A.13(2) of the Listing Rules, with effect from November 21, 2025.
Ms. Lam Wai Yi has been appointed as the Joint Company Secretary, authorized representative, and legal process agent of the Company, with effect from November 21, 2025.
Related Articles

Hunan Silver (002716.SZ) director Rongqi resigns

Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.

China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
Hunan Silver (002716.SZ) director Rongqi resigns

Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.

China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


